- Home
- USEA vs PRPH Comparison
USEA vs PRPH Comparison
Compare USEA & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- PRPH
- Stock Information
- Founded
- USEA 2004
- PRPH 1989
- Country
- USEA Greece
- PRPH United States
- Employees
- USEA N/A
- PRPH N/A
- Industry
- USEA Marine Transportation
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- USEA Consumer Discretionary
- PRPH Health Care
- Exchange
- USEA Nasdaq
- PRPH Nasdaq
- Market Cap
- USEA 17.2M
- PRPH 15.5M
- IPO Year
- USEA N/A
- PRPH 1997
- Fundamental
- Price
- USEA $1.84
- PRPH $0.70
- Analyst Decision
- USEA Strong Buy
- PRPH Strong Buy
- Analyst Count
- USEA 1
- PRPH 1
- Target Price
- USEA $6.00
- PRPH $11.00
- AVG Volume (30 Days)
- USEA 74.9K
- PRPH 232.3K
- Earning Date
- USEA 02-18-2025
- PRPH 11-13-2024
- Dividend Yield
- USEA 16.30%
- PRPH N/A
- EPS Growth
- USEA N/A
- PRPH N/A
- EPS
- USEA N/A
- PRPH N/A
- Revenue
- USEA $46,160,000.00
- PRPH $12,753,000.00
- Revenue This Year
- USEA $27.55
- PRPH $36.93
- Revenue Next Year
- USEA $5.76
- PRPH $132.05
- P/E Ratio
- USEA N/A
- PRPH N/A
- Revenue Growth
- USEA 11.18
- PRPH N/A
- 52 Week Low
- USEA $1.72
- PRPH $0.64
- 52 Week High
- USEA $3.00
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- USEA 32.15
- PRPH 28.79
- Support Level
- USEA $1.72
- PRPH $0.66
- Resistance Level
- USEA $1.99
- PRPH $0.74
- Average True Range (ATR)
- USEA 0.09
- PRPH 0.06
- MACD
- USEA 0.00
- PRPH 0.05
- Stochastic Oscillator
- USEA 36.25
- PRPH 34.44
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.